arrow
M

Massimiliano Filosto

nemo-brescia clinical center for neuromuscular diseases
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Refining Electrophysiological Criteria in CIDP and MMN: Toward a Unified Definition of Motor Conduction Block and Proximal Temporal Dispersion

在慢性炎性脱髓鞘性多发性神经病和运动神经病中优化电生理标准:迈向运动传导阻滞和近端时间离散的统一定义

2026-09-030
OAAI
Inter-centre heterogeneity, temporal evolution, and factors associated with treatment selection and outcomes in chronic inflammatory demyelinating polyradiculoneuropathy: a multicentre, combined prospective and retrospective observational study

多中心异质性、时间演变及与治疗选择和结局相关的因素在慢性炎症性脱髓鞘多发性神经根神经病中的研究:一项多中心、前瞻性与回顾性相结合的观察性研究

2026-06-230
OA
Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)

对Patisiranitaly研究中Patisiran治疗的家族性转甲状腺素蛋白淀粉样变性患者多中心队列中F64L突变的深度表型分析

2026-06-010
OA
Diet and nutrition in patients with neuromuscular disorders; as lifestyle factors affecting clinical parameters and quality of life: a narrative systematic review

神经肌肉疾病患者的饮食与营养;作为影响临床参数和生活质量的生活方式因素:一篇叙述性系统综述

2026-05-220
OAAI
Bridging Past and Future: The Evolution of Genetic Diagnosis in FSHD and the Role of Emerging Technologies in a Globalized Framework

连接过去与未来:FSHD中遗传诊断的演变及新兴技术在全球化框架中的作用

2026-04-150
PRE
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia

Kyriakides, T.; Aleksovska, K.; Angelini, C.; Argov, Z.; Claeys, K.G.; de Visser, M.; FIlosto, M.; Jovanovic, I.; Kostera-Pruszczyk, A.; Molnar, M.J.; et al. EAN 2024关于寡/无症状高肌酸激酶血症诊断方法的指南。Eur. J. Neurol. 2026, 33, e70493. [Google Scholar] [CrossRef] [PubMed]

2026-01-310
OAAI
Quantitative MRI Biomarkers for Early Muscle Involvement in Late Onset Pompe Disease
2026-01-190
PRE
Late-onset Pompe’s disease in pediatrics: results from an Italian national survey on 38 patients and proposal of a targeted diagnostic algorithm

儿科迟发性庞贝病:来自一项意大利全国性调查的38例患者的结果及针对性诊断算法的提出

2025-11-280
OAAI
Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients

评估IBM-FRS总分及特定功能领域在一大样本包涵体肌炎患者中的表现

2025-11-190
PRE
Unveiling MYH2-related myopathy: Histological-genetic insights from a case series and systematic review

揭示MYH2相关肌病:来自病例系列和系统综述的组织学-遗传学见解

2025-11-180
OA
Understanding Long-Term Survival in ALS: A Cohort Study on Subject Characteristics and Prognostic Factors

理解ALS的长期生存:一项关于受试者特征和预后因素的研究队列

2025-10-170
OAAI
Landscape Analysis of COL6A1, COL6A2, and COL6A3 Pathogenic Variants in a Large Italian Cohort Presenting with Collagen VI-Related Myopathies: A Nationwide Report

COL6A1、COL6A2和COL6A3致病性变异在呈现VI型胶原蛋白相关肌病的大型意大利队列中的景观分析:一项全国性报告

2025-10-080
OAAI
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy

多灶性运动神经病中传导阻滞以外的神经传导异常。对诊断标准准确性的影响

2025-09-230
OAAI
Targeted plasma proteomics uncover proteins associated with KIF5A-linked SPG10 and ALS spectrum disorders

靶向血浆蛋白质组学揭示了与KIF5A相关的SPG10和ALS谱系障碍相关的蛋白质

2025-08-270
OAAI
The Role of Whole-Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo-Humeral Muscular Dystrophy Cases

全外显子组测序和甲基化分析在解开复杂面肩肱型肌营养不良病例中的作用

2025-08-110
PRE
Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study

评估拉莫三嗪作为抗肌强直剂在1型肌强直性营养不良(DM1)中的安全性与有效性:一项纵向、开放标签、初步研究

2025-08-020
OAAI
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis

遗传性甲状腺素运载蛋白淀粉样变性在具有红旗标志的CIDP患者中的患病率:一项多中心遗传筛查和误诊分析

2025-07-160
PRE
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa

意大利晚发型庞贝病(LOPD)患者接受阿糖苷酶α治疗10年和15年后的队列分析

2025-07-110
PRE
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis

皮质兴奋性作为肌萎缩侧索硬化症的预后和表型分层生物标志物

2025-06-250
OAAI